Is AI/ML Innovations Inc. (AIMLF) a Buy, Sell, or Hold?
OTC : AIMLF
AI/ML Innovations Inc.
$0.0343 USD
$0 (0.0%)
- Volume
- 200
- Average Volume
- 153.84K
- Market Capitalization
- $5.77M
- P/E Ratio
- -1.32
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.06
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.76
Company Overview
OTC
John Paul Duffy
Medical - Healthcare Information Services
Healthcare
AIMLF
5
CA
USD
Liquidity Metrics
0.72
0.76
0.76
0.31
0.00
Sales & Valuation
$167.31K
91.10
45.22
-2.18
-0.02
Profitability
-$0.034
-$4.59M
-5622.25%
-5621.27%
-504.80%
-433.70%
P/E Metrics
-1.32
-0.15
-0.15
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-49.07
1/9
-$337.59K
$1.63M
$1.41M
-$6.59M
Key Metrics (TTM)
$8.17M
65.08
-1.27
0.76
-504.80%
-404.93%
-55.55%
-62.34%
277 days
Company Executives
| Name | Title |
|---|---|
| Andrea L. Ruth | Head of Quality, Clinical, & Regulatory |
| Erik Suokas | Chief Operating Officer |
| Alan Rabinowitz | Chief Medical Officer, Member of Medical Advisory Board & Director of Medical Partnerships |
| John Paul Duffy | President, CEO & Executive Chairman |
| Kendra Low | Company Secretary |
| Esmat Naikyar | Chief Product Officer |
| Terence Lee | Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About AI/ML Innovations Inc. (OTC:AIMLF) Stock
Specializing in digital healthcare, AI/ML Innovations Inc. harnesses advanced artificial intelligence and machine learning technologies. The company's core offering is an innovative, patent-pending system for personal health monitoring and management. This platform enables caregivers, patients, and medical professionals to access and utilize vital data, aiming to enhance recovery outcomes and foster healthy living. Additionally, they develop digital health software and wearable technologies. The firm was incorporated in 2009 and, after operating as AIML Resources Inc., rebranded to AI/ML Innovations Inc. in November 2020. Its headquarters are located in Victoria, Canada. ...
AI/ML Innovations' Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) Certification
2026-08-11 07:00:00
Quality Management System Certification Strengthens NeuralCloud's Regulatory Readiness for ECG Software-as-a-Medical-Device Platform TORONTO, ON / ACCESS Newswire / August 11, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company advancing artificial intelligence and neural-network-based technologies for digital health, is pleased to announce that its wholly owned subsidiary, NeuralCloud Solutions Inc. ("NeuralCloud"), has achieved ISO 13485:2016 certification under the Medical Device Single Audit Program ("MDSAP") for its quality management system. The certification, issued by TÜV USA, Inc., applies to NeuralCloud's quality management system for the design, development, production, and distribution of Software as a Medical Device ("SaMD") for ECG analysis, including advanced PQRST waveform delineation, interval computation, arrhythmia analytics, signal quality scoring, and artifact reporting.
AI/ML Innovations Announces Completion of Share Issuance
2026-07-02 17:05:00
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / July 2, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB) is pleased to announce that it has completed its previously announced share for debt issuance with certain service providers of the Company pursuant to which the Company has issued an aggregate of 3,560,334 common shares (the "Subject Shares") at a deemed price of Cdn$0.05 per Subject Share in consideration of past services and satisfaction of outstanding indebtedness (the "Debt Settlement"). The Subject Shares are subject to a statutory hold period expiring on November 3, 2026.
2026-06-02 07:00:00
Appointments bring more than 50 combined years of cardiac monitoring, ECG overread (the expert clinical review of ECG recordings by trained technicians and cardiologists), and regulatory validation experience to NeuralCloud's clinical and operational leadership team. Leadership additions strengthen AI/ML's clinical-governance and operational readiness as it advances its neural-network ECG signal-processing technology through regulatory review toward potential future commercialization.
Frequently Asked Questions
-
What is the current AI/ML Innovations Inc. (AIMLF) stock price?
-
AI/ML Innovations Inc.(OTC:AIMLF) stock price is $0.0343 in the last trading session. During the trading session, AIMLF stock reached the peak price of $0.0625 while $0.0015 was the lowest point it dropped to. The percentage change in AIMLF stock occurred in the recent session was 0.0% while the dollar amount for the price change in AIMLF stock was $0.
-
AIMLF's industry and sector of operation?
-
The OTC listed AIMLF is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of AIMLF?
-
Andrea L. Ruth | Head of Quality, Clinical, & Regulatory
Erik Suokas | Chief Operating Officer
Alan Rabinowitz | Chief Medical Officer, Member of Medical Advisory Board & Director of Medical Partnerships
John Paul Duffy | President, CEO & Executive Chairman
Kendra Low | Company Secretary -
How many employees does AIMLF have?
-
Number of AIMLF employees currently stands at 5. AIMLF operates from 645 Fort Street, Victoria, BC V8W 1G2, CA.
-
Link for AIMLF official website?
-
Official Website of AIMLF is: https://aiml.health
-
How do I contact AIMLF?
-
AIMLF could be contacted at phone #+1 778 405 3883 and can also be accessed through its website. AIMLF operates from 645 Fort Street, Victoria, BC V8W 1G2, CA.
-
How many shares of AIMLF are traded daily?
-
The average number of AIMLF shares traded daily for last 3 months was 153.84K.
-
What is the market cap of AIMLF currently?
-
The market value of AIMLF currently stands at $5.77M with its latest stock price at $0.0343